Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 108631

In scope icon M 6 D
QID 108631 (Type "108631" in App Search)
A 72-year-old man presents to the primary care clinic for evaluation of a 1 month history of progressive fatigue and weight loss. His past medical history is significant for hypercholesterolemia, type 2 diabetes mellitus, aortic stenosis, and chronic renal insufficiency. He endorses being well-rested after waking from sleep but rapidly becoming fatigued during the day. In addition, he states that he has lost 15 lbs over the previous month. His temperature is 98.3°F (36.8°C), pulse is 100/min, blood pressure is 110/85 mmHg, respirations are 16/min, and oxygen saturation is 96% on room air. Physical exam is notable for conjunctival pallor and scattered areas of ecchymoses. His laboratory results are shown below:

Serum:
Na+: 140 mEq/L
K+: 4.0 mEq/L
Cl-: 101 mEq/L
HCO3-: 22 mEq/L
BUN: 30 mg/dL
Glucose: 160 mg/dL
Creatinine: 1.9 mg/dL

Leukocyte count: 1,100/mm^3
Absolute neutrophil count 920/mm^3
Hemoglobin 8.4 g/dL
Platelet count: 45,000/mm^3
Mean corpuscular hemoglobin concentration: 34%
Red blood cell distribution width: 12.0%
Mean corpuscular volume: 92 µm^3
Lactate dehydrogenase: 456 IU/L
Haptoglobin 120 mg/dL
Fibrinogen 214 mg/dL

A bone marrow biopsy is performed which shows cells that are CD19+, CD20+, CD11c+, and stain with acid phosphatase 5 and tartrate-resistant. Which of the following is the next best step in the treatment of his disorder?